Cravath-Led Viatris Unveils Ophthalmology Buys Worth $750M
Health care company Viatris Inc. announced on Monday that it had reached agreements to purchase Oyster Point Pharma and Famy Life Sciences in order to create an ophthalmology franchise, with guidance...To view the full article, register now.
Already a subscriber? Click here to view full article